Comparative study on the effects of different therapeutic methods in preventing and treating nonalcoholic fatty liver in rats

Journal of Chinese Integrative Medicine

Volumn 10, Issue 10, 2012, Pages 1120-1126

  Liu, Tao ^a   Yang, Li li ^a   Zhang, Li ^a   Song, Hai yan ^a   Li, Dong fei ^b   Ji, Guang ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Fatty liver; Rats; Therapeutic methods (TCM)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHINESE DRUG; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINGGUI ZHUGAN TANG; LIZHONG TANG; SHENZHUO TANG; SIJUNZI TANG; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EPIDIDYMIS FAT; LIVER WEIGHT; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; STAINING; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT;

ANIMALS; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; FATTY LIVER; LIPID METABOLISM; LIVER; MALE; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 84868230774     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20121008     Document Type: Article

References (22)

1. Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. Zhonghua Gan Zang Bing Za Zhi, 2010, 18(3): 163-166. Chinese.
2. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis[J]. Hepatology, 2006, 43(2 Suppl 1): S99-S112.
3. De Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears[J]. J Hepatol, 2008, 48(Suppl 1): S104-S112.
4. Angulo P. GI epidemiology: nonalcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2007, 25: 883-889.
5. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China[J]. J Hepatol, 2009, 50: 204-210.
6. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference[J]. Hepatology, 2003, 37(5): 1202-1219.
7. Fon Tacer K, Rozman D. Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation[J]. J Lipids, 2011, 2011: 783976.
8. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A; Asia-Pacific Working Party for NAFLD. What are the risk factors and settings of non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol. 2007; 22(6): 794-800.
9. Fan JG. Paying attention to the management of chronic viral hepatitis patients with fatty liver[J]. Zhonghua Gan Zang Bing Za Zhi, 2009, 17(11): 801-803. Chinese.
10. Donthamsetty S, Bhave VS, Mitra MS, Latendresse JR, Mehendale HM. Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity[J]. Hepatology, 2007, 45(2): 391-403.
11. Mao ZM, Song HY, Yang LL, Liu T, Li DF, Zheng PY, Liu P, Ji G. Effects of the mixture of Swertia pseudochinensis Hara and Silybum marianum Gaertn extracts on CCl4-induced liver injury in rats with non-alcoholic fatty liver disease[J] J Chin Integr Med, 2012, 10(2): 193-199. Chinese with abstract in English.
12. Deng ZJ. Traditional Chinese formula[M]. Beijing: Chinese Press of traditional Chinese medicine, 2003. 135, 151, 309-310. Chinese.
13. Li F. Senior series of traditional Chinese medicine-Traditional Chinese formula[M]. Beijing: People's Medical Publishing House, 2001. 776. Chinese.
14. Chen CX. Pharmacology of traditional Chinese medicine[M]. Shanghai: Shanghai Scientific and Technical Publishers, 2006. 191. Chinese.
15. Cheng HY. Literature research on traditional Chinese medicine names for fatty liver[J]. Xinjiang Zhong Yi Yao, 2008, 26(6): 12-14. Chinese.
16. Friedman LS, Keefe EB. Handbook of liver disease. 2nd ed. Translated by Niu JQ, Zhang QQ, Ding YH[M]. Tianjin: Tianjin Science and Technology Translation and Publishing Corp, 2007. 97. Chinese.
17. Fang YZ. Seven speeches of research on differentiation of symptoms and signs[M]. Beijing: People's Medical Publishing House, 1979. 96. Chinese.
18. You ZJ. The essence of synopsis of the golden chamber[M]. Beijing: Chinese Press of Traditional Chinese Medicine, 1992. 75. Chinese.
19. Li DY. Treatise on the spleen and stomach[M]. Beijing: People's Medical Publishing House, 2005. 10. Chinese.
20. Liu T, Tang ZP, Ji G. Treatment of nonalcoholic fatty liver disease based on traditional Chinese medicine therapies for warming yang to activate qi[J] J Chin Integr Med, 2011, 9(2): 135-136. Chinese with abstract in English.
21. Xie M. The logic proposition of correlation between syndrome and prescription and its significance[J]. Beijing Zhong Yi Yao Da Xue Xue Bao, 2003, 26(2): 11-12. Chinese.
22. Xu ZJ, Fan JG, Wang GL, Ding XD, Tian LY, Zheng XY. Rat model of nonalcoholic steatohepatitis with fibrosis by a fat-rich diet[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2002, 10(4): 392-396. Chinese with abstract in English.